Exhibit 99.1 Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results BRISBANE, Calif., May 6, 2025 – Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights and financial results for the first quarter ended March 31, 2025. Major Upcoming Milestones • Anticipated announcement of the primary ...